Target, Home Depot,...
Health Care: Drugs
Ampio Pharmaceuticals Inc. (AMPE: NASDAQ)
$5.03 0.03 | 0.60%
05/17/13 - 04:00 PM ET
114.98K / 226.30K
Vol / Avg. Vol:5.05 / 5.00
Open / Prev. Close:4.91 - 5.05
Today's Range:2.55 - 6.25
52 Wk Range:39.28%
Performance YTD:TheStreet Rating:
Portfolios with AMPE
- Portfolio NameUser Type
- UserFlying Monkey King's Actuals
- ContributorStocks Under-$10 Setting Up...
- UserFirst Try
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
Latest AMPE Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Ampio's Eye Drug Trial Design Won't Pass FDA Muster 04.02.13 | 09:04 am
- 5 Stocks Under $10 Set to Soar 09.20.12 | 01:09 pm
- A Biotech Short Seller Responds To Critics 07.17.12 | 08:07 am
- Ampio Insiders, Aided by PR Blitz, Soon Free to Sell Millions of Shares 07.02.12 | 01:07 pm
- Biotech Stock Mailbag: Osiris, Arena, Ampio 06.22.12 | 06:06 am
- Ampio Spins A Tale of Curing Blindness 06.11.12 | 03:06 pm
- Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm 04.05.12 | 05:04 am
- 6 Stocks Under $10 Moving Higher 12.14.11 | 01:12 pm
Press Releases for AMPE
- Ampio Pharmaceuticals Announces Participation At The UBS Global Healthcare Conference - PR Newswire 05.13.13 | 08:05 am
- Ampio Pharmaceuticals Completes Enrollment In Run-In SPRING Study Of Ampion In Osteoarthritis Of The Knee - PR Newswire 04.25.13 | 08:04 am
- Ampio Receives FDA Clearance To Initiate Clinical Trial Of Ampionâ¿¢ For The Treatment Of Osteoarthritis Of The Knee: Patient Treatments Have Begun. - PR Newswire 04.02.13 | 04:04 am
- Ampio Receives FDA Acceptance Of Its Patient Outcome For Premature Ejaculation (POPE) Questionnaire, Paving The Way For Its US Pivotal Trial On Zertaneâ¿¢ - PR Newswire 03.11.13 | 04:03 am
- Ampio Pharmaceuticals Initiates Clinical Trial Of Optinaâ¿¢ In Diabetic Macular Edema (DME): First Patient Dosed - PR Newswire 02.27.13 | 04:02 am
- Ampio Pharmaceuticals Modifies Ampionâ¿¢ IND For Osteoarthritis Of The Knee To Include A Dose Escalation Run-In Study And Prepares To Launch Pivotal Clinical Trial - PR Newswire 02.25.13 | 04:02 am
- Ampio Forms Luoxis Diagnostics To Commercialize ORP Technology - PR Newswire 02.11.13 | 04:02 am
- Ampio Pharmaceuticals Announces Participation At Upcoming Investor Conference - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals Announces Active IND For Optinaâ¿¢ For The Treatment Of Diabetic Macular Edema (DME) - PR Newswire 01.22.13 | 04:01 am
- Ampio Pharmaceuticals, Inc. (AMPE) Announces Appointment Of Josh Disbrow As Chief Operating Officer Effective December 15, 2012 - PR Newswire 11.28.12 | 04:11 am
Partner Headlines for AMPE
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- BioPharma Stock Movers For Wednesday, August 29 - Seeking Alpha 08.29.12 | 09:08 am
- Ultimate Market Recap: Barclays Chairman Bows Out, ATPG Looking Slick - Wall St. Cheat Sheet 07.02.12 | 10:07 am
- Morning Market Movers - Benzinga 07.02.12 | 09:07 am
- Arena Pharma FADES Below $10 and 4 High Demand Stocks ATTRACTING Eyes - Wall St. Cheat Sheet 07.02.12 | 02:07 am
- Weekly Market Wrap: Stocks RALLY, Gold SPARKLES, Apple's New Products REVEALED - Wall St. Cheat Sheet 06.17.12 | 12:06 pm
- Company News for June 12, 2012 - Corporate Summary - Zacks 06.12.12 | 10:06 am
- These 5 Small Cap Stocks Are Up Better Than 10% Today - Benzinga 06.11.12 | 01:06 pm
- 4 Contrarian Stock Climbers in Trading Action as Centene Falls Hard - Wall St. Cheat Sheet 06.11.12 | 01:06 pm
- Market Wrap: Gold GLITTERS as Apple's Innovation is Analyzed - Wall St. Cheat Sheet 06.11.12 | 10:06 am
